Radiometer logo

At Danaher, we're commited to accelerating the power of science and technology to improve human health.

  • Request an appointment
    Request an Appointment

    Contact Info


    By submitting this form, I acknowledge that I have reviewed and understood the data privacy notice.

    All fields must be filled!

Join us at ADLM 2026 Clinical Lab Expo

July 26-30 | Anaheim, CA | Danaher Booth #3237 



Explore our products

Attend our presentations

Get a demo

Request an appointment
Request an appointment

Contact Info


By submitting this form, I acknowledge that I have reviewed and understood the data privacy notice.

All fields must be filled!

Join us at ADLM 2026 Clinical Lab Expo

We’re Accelerating the Power of Science and Technology to Improve Human Health.

Our impact spans from lab to life, speeding the translation of advanced science to real-world impact and improving the lives of millions of patients globally.

Guided by our culture of continuous improvement, we’re turning scientific potential into progress and helping providers deliver accurate answers sooner —because time saves lives, and speed with certainty matters.

 

When Time Saves Lives, Speed with Certainty Matters

At Danaher we unite diagnostics, life sciences, and biotech to deliver faster, smarter solutions—because lives depend on it.

The impact of our industry-leading businesses - Beckman Coulter Diagnostics, Beckman Coulter Life Sciences, Cepheid, Cytiva, HemoCue, Leica Biosystems, Radiometer and SCIEX – spans from Lab to Life, speeding the translation of advanced science to real-world impact.

 

Our Events

For more than 70 years, Radiometer has been at the forefront of acute care diagnostics. This year at ADLM, we are sharing new evidence and insights that highlight the value of timely blood gas testing and the crucial role of the preanalytical phase in achieving reliable results.


 

In-booth presentation
Wednesday, July 29th – 10:00 AM (30 min) | Booth #3237 (Danaher booth)
"Every Minute Counts: Delivering Speed and Certainty in Bedside Blood Gas Testing"
Presenter: Dr. William Clarke, PhD, MBA, DABCC
Industry workshop
Wednesday, July 29th – 03:00 PM (1 h) | Theater Stage 3
"Convergence of real-world data from U.S. practice survey and the new CLSI C46 Blood Gas Guideline: mastering the preanalytical phase"
Presenter: Dr. John Toffaletti, PhD
Panelists:
Dr. Lorin Bachmann, PhD, DABCC
Dr. Xander M. R. van Wijk, PhD, DABCC
Poster presentation
Tuesday, July 28th – 01:30 PM | Poster Hall
Poster A-355
"Blood Gas Sample Storage Time Recommendations and Age Tracking Practices: A Survey of Current Practices Across U.S. Health Care Setting"
Poster A-356
"Survey of Preanalytical Errors in Blood Gas Sample Collection and Analysis: Frequency, Impact, and Improvement Priorities Across U.S. Health Care Setting"
Presenter: Jamie Acero, MHA

Dr. William Clarke is the Professor of Pathology at Johns Hopkins University School of Medicine, Baltimore, Maryland.

Dr. Clarke received his Ph.D. in Analytical Chemistry from the University of Nebraska in Lincoln in 2000, followed by a post-doctoral fellowship in Clinical Chemistry at the Johns Hopkins School of Medicine, ending in 2002.  In addition, he received an MBA focused on medical services management from the Carey School of Business at Johns Hopkins in 2007. 

Following his post-doctoral fellowship, he remained at Johns Hopkins where he is a Professor in the Department of Pathology, the Vice Chair of Pathology for Quality and Regulatory Affairs, and Director of Clinical Chemistry for the hospital.  His research interests include clinical mass spectrometry, clinical toxicology, point-of-care testing, and development/validation of biomarkers for use in drug management.  Dr. Clarke has published over 210 peer-reviewed manuscripts or book chapters, is a Co-Editor of the textbook Contemporary Practice in Clinical Chemistry, and is Editor-in-Chief of Clinica Chimica Acta.

Dr. John Toffaletti is the Professor of Pathology, Director of the Blood Gas Laboratory, the Clinical Pediatric Laboratory, and several Outpatient Laboratories at Duke University Medical Center.  He is also the Chief of Clinical Chemistry at the Durham VA Medical Center.

Dr. John Toffaletti has recently chaired the CLSI document development committed updating the 3rd edition of C46 on Blood Gas and Critical Care Testing.

After completing clinical chemistry training programs at UNC and Hartford Hospital, John Toffaletti has worked in the Clinical Laboratories at Duke University Medical Center since 1979, where he is now Professor of Pathology, Director of the Blood Gas Laboratory, the Clinical Pediatric Laboratory, and several Outpatient Laboratories.  He is also the Chief of Clinical Chemistry at the Durham VA Medical Center.

He has written or presented numerous workshops, books, chapters, and seminars on the interpretation of blood gas, cooximetry, ionized calcium, magnesium, lactate (sepsis), kidney function tests (creatinine, cystatin C, GFR), and viscoelastic testing (ROTEM and TEG).  He has recently chaired the CLSI document development committed updating the 3rd edition of C46 on Blood Gas and Critical Care Testing. Dr Toffaletti’s research interests include sample collection, pre-analytical errors, analysis, and clinical use of these tests.

Dr. Lorin Bachmann is the Professor of Pathology, Co-Director of Clinical Chemistry and Director of the Blood Gas Laboratory at the Virginia Commonwealth University (VCU) Health System.

She is a member of the Document Development Committee for the Clinical and Laboratory Standards Institute (CLSI) document C46, Blood Gas, pH, Cooximetry, and Related Measurements – Third Edition.  Dr. Bachmann currently serves as a member of the CLSI Board of Directors and as an advisor for the CLSI Chemistry and Toxicology Expert Panel. She is also a member the College of American Pathologists (CAP) Standards Committee. Dr. Bachmann’s clinical and research interests include development of laboratory practice guidelines, standardization of clinical laboratory assays and quality assurance.

Dr. Xander M. R. van Wijk is an Associate Professor in Laboratory Medicine at the University of California San Francisco, where he oversees Clinical Chemistry and Sendout testing. He is also the Principal Consultant at van Wijk Consulting LLC.

Dr. Xander is a member of the CLSI document development committed updating the 3rd edition of C46 on Blood Gas and Critical Care Testing. Dr. van Wijk extensive background includes roles such as Senior Medical Director at Beckman Coulter Diagnostics, where he contributed to medical strategy and innovation, and Assistant Professor at the University of Chicago, where he oversaw multiple laboratory specialties. His research and experience have established him as a respected authority in the field, with over 60 peer-reviewed articles, book chapters, and several prestigious awards. His research interests are core laboratory diagnostics including laboratory developed tests, cardiac biomarkers, toxicology, pharmacogenomics, and blood gas analysis.

Jamie Acero is a Medical Science Liaison at Radiometer, where she partners with healthcare professionals and key opinion leaders to bring clinical and scientific insights to the forefront of diagnostic decision-making. She has nearly 20 years of experience in laboratory medicine and blood gas diagnostics.

Jamie brings deep expertise, a strong clinical perspective, and a passion for advancing patient care through collaboration and innovation.

She brings technical information to life, turning it into real-world insights and delivering engaging education that empowers confident decision-making in point-of-care testing. Jamie holds a Master of Science in Healthcare Administration and is a Certified Point of Care Professional

Icon - device connectivity

AQURE 3rd Party Connectivity

This year, for the first time, we will showcase 3rd party connectivity with AQURE with connections to other products in our Danaher portfolio such as Cepheid GeneXpert, Hemocue 201 DM Glu and Hemocue 201 DM Hb.

Your partner every step of the way

Before, during, and after analysis

Radiometer’s solution supports you in every stage of your blood gas testing workflow.

Preanalytical stage

Preventing errors before analysis begins

Many blood gas testing errors occur before the analysis even begins. The thoughtfully designed components of Radiometer's blood gas solution - from syringes and capillary tubes to analyzers and IT systems-work together to support preanalytical excellence.

Mastering the preanalytical phase

Analytical stage

Proven performance

We offer a flexible blood gas diagnostic solution that can fit seamlessly into your acute care testing and hospital workflow.

Explore our full blood gas testing solution

Postanalytical stage

Results, fast and exactly where you need them

Radiometer AQURE IT system system automatically sends results to any connected hospital system. With integrated support, governance, and compliance, you can trust every result reaches the right place - every time.

Explore also how AQURE helps with accreditaiton

Clinical decision support

Optimize clinical workflows with Etiometry

In the Intensive Care Unit (ICU), every second counts. Changes in patient status can happen quickly and without warning.

To support clinicians’ timely understanding of their patients’ condition, we’ve partnered with Etiometry, a leader in clinical decision-support software for critical care. The powerful platform supports healthcare professionals in making data-driven decisions that improve both patient outcomes and hospital economics.

Clinical decision support

Request an appointment

Request an appointment


Contact details

Workplace details


By submitting this form, I acknowledge that I have reviewed and understood the data privacy notice.

All fields must be filled!


MAPSSS-001456 R1

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.